Global Trehalose Market Overview
According to Global Market Monitor, the global Trehalose market size will be $478.09 million in 2024 with a CAGR of 8.64% from 2024 to 2029.
Trehalose is a non-reducing sugar that has a similar chemical structure and properties to sucrose, and it has a recognized safety status granted by the US Food and Drug Administration and novel food status in the European Union (EU). Trehalose is half as potent as table sugar (sucrose) in sweetness and has a similar glycemic index. Trehalose can mask unpleasant tastes and odors and improve the quality and acceptability of finished medicines (dry syrups, liquid preparations, tablets, and chewable tablets). Trehalose 100PH and Trehalose SG are pharmaceutical-grade Trehalose. Trehalose 100PH is primarily used as an excipient to stabilize proteins and for other pharmaceutical and medical applications. Trehalose SG is an injectable grade (low endotoxin) and can be used to stabilize protein drugs such as monoclonal antibodies and other protein molecules that are often degraded by freezing, freeze-drying, and long-term storage.
Authoritative Certification Helps the Stable Development of the Industry.
Trehalose has been reviewed by all major regulatory bodies in the world, found to be safe for use in food, and approved as a novel food in the European Union. Trehalose safety certification attracts more consumers and provides more opportunities for industry participants, which is conducive to the healthy development of the industry. In addition, Trehalose is also known as the "sugar of life" in the scientific community. The international authoritative "Nature" magazine published a special article on the evaluation of Trehalose in July 2000, which pointed out: "For many organisms, the existence of Trehalose or not means life or death." Trehalose is about 45% as sweet as sucrose at concentrations above 22%, but when the concentration is reduced, its sweetness declines faster than sucrose.
Market Competition
The Asia Pacific Trehalose market holds a major share and increasing demand for Trehalose from the food and beverage and pharmaceutical industries due to the rapid urbanization of the region is expected to drive the revenue growth in Asia Pacific during the forecast period. At the same time, with the economic growth in the Asia-Pacific region, the progress of science and technology, and the development of modern enterprises, the demand for Trehalose is also increasing. At the same time, the rapid development of the food and beverage, pharmaceutical, and cosmetics industries in the Asia-Pacific region also means that Trehalose has a huge market potential in the Asia-Pacific region. All in all, the Asia-Pacific Trehalose market is expected to grow at a faster rate during the forecast period due to the presence of major players in the region. Increasing personal disposable income and spending power, coupled with population growth in countries in the region, which in turn increases the demand for the food and beverage, pharmaceutical, and cosmetic industries, is expected to drive the growth of the Trehalose market in Asia Pacific during the forecast period.
Company Name |
Hayashibara |
Website |
www.hayashibara.co.jp |
Establish Date |
1883 |
Manufacturing Bases |
Japan |
Sales Regions |
Worldwide |
Competitors |
SinozymeBiotechnology, Meihua Group |
We provide more professional and intelligent market reports to complement your business decisions.